ADMA Biologics Inc Stock News

Researchers at NYU Langone on March 24 launched one of the nation's largest hydroxychloroquine studies and enrolled their first patient 10 days later.

COVID-19 – Fauci Sees May 1 Restart as Overly Optimistic

The Dow Jones Industrial Average and the S&P 500 fell for the first time in three sessions as investors braced for the earnings season.

Economists’ offer many scenarios. One encouraging sign: The nation bounced back sharply after a somewhat similar downturn in the early 1980s.

The stock market's plunge into a bear market this year was only matched by its blistering rally off its lows.

Dying from COVID-19 is more likely for stricken residents of U.S. counties with higher levels of long-term air pollution, according to a study released this...

Bear markets that saw 33% declines took 7½ years to regain their previous highs.

ADMA Biologics Inc (NASDAQ:ADMA)’s stock price fell 7.5% on Tuesday . The stock traded as low as $2.86 and last traded at $2.94, 2,256,863 shares traded hands during trading. A decline of 6% from th

The market is searching for healthcare stocks that could be a major player in the Coronavirus Crisis. My speculative portfolio is loaded with some of these COVI

Gainers BioSig Technologies, Inc. (NASDAQ: BSGM) shares gained 42.4% to close at $5.14 on Friday. BioSig is expected to host telebriefing on development updates regarding...

A growing number of U.S. employers, including Walmart and Amazon, are using temperature checks to screen employees for the coronavirus, but medical experts warn that some who are sick don't have a fev

Aimed at facilitating nationwide access to antibody-rich blood products for COVID-19 patients, the FDA has instituted an emergency investigational new drug application (eIND) process for convalescent

Q4 2019 ADMA Biologics Inc Earnings Call